High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
Adiponectin (ADPN) prevents the development/recurrence of cardiovascular events via its anti-atherogenic effects. However, few long-term studies have examined the changes in serum ADPN levels and arterial calcification seen in renal allograft recipients.The effects of the serum ADPN level on arteria...
Main Authors: | Kanae Nomura-Nakayama, Hiroki Adachi, Nobuhiko Miyatake, Norifumi Hayashi, Keiji Fujimoto, Hideki Yamaya, Hitoshi Yokoyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5931493?pdf=render |
Similar Items
-
Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients.
by: Nobuhiko Miyatake, et al.
Published: (2020-01-01) -
Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.
by: Hiroki Adachi, et al.
Published: (2016-01-01) -
Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study
by: Keiji Fujimoto, et al.
Published: (2022-01-01) -
Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.
by: Lena Berchtold, et al.
Published: (2016-01-01) -
Vascular Calcification in Diabetic Kidney Disease
by: Olivier Phan, et al.
Published: (2022-12-01)